S&P 500 Declines as Higher Oil Prices, AI Capex Spending, and Risk of Rate Hikes Scare Wall Street Bulls
The S&P 500 (Index: SPX) fell a little under 0.7% during the trading week ending on Friday, 24 July 2026. The index ended the week at 7,408.70, which is 201.08 points (or 2.6%) below its all time record high of 7,609.78 from 2 June 2026.
The past week didn’t see a single catalyst to weigh on stock prices, but rather three of them. Oil prices briefly shot up over $100 per barrel with the Iran war’s disruption to oil shipping in the Middle East. The risk of higher inflation prompted the second catalyst of the specter of higher interest rates to rear its ugly head.
But the third catalyst was perhaps the most significant. Outsized capital expenditures by AI tech giants like Alphabet (NASDAQ: GOOGL and GOOG) and speculated for firms like Meta Platforms sent their stock prices sharply lower from where they closed the previous week. That action pulled the S&P 500 lower overall thanks to their outsized shares of the total valuation of all the stocks within the market cap-weighted index.
Overall, the S&P 500′s trajectory ticked down to toward the lower end of the redzone forecast range on the latest update of the alternative futures chart.
As we’re reaching the end of the redzone forecast range, we find the level of the index is consistent with investors fixing their attention on either the current quarter of 2026-Q3 or the more distant future quarter of 2026-Q4. Investors have reason to focus on each of these quarters thanks to their status as quarters in which the Federal Reserve will most likely hike short term interest rates in the U.S. The CME Group’s FedWatch Tool now projects two quarter point rate hikes in the months ahead. The first would occur after the Fed meets on 16 September (2026-Q3) and the second would take place on 9 December (2026-Q4). The FedWatch tool’s projections are biased toward potential additional rate hikes in 2027 with the most likely timing in the first half of the year.
If, when, and by how much the Fed might change interest rates however will be affected by the random onset of new information. Here are the market moving headlines from the trading week ending on Friday, 24 July 2026:
- Monday, 20 July 2026
-
- Signs and portents for the U.S. economy:
- Oil reverses as Iranian comments interpreted as chance for fresh negotiations
- US pump prices cross $4 again on renewed fighting in the Middle East
- Why oil prices haven’t gone crazy despite 5 months of US-Iran war
- Bigger bailout developing in China:
- ECB minions relieved to see oil price surge isn’t causing Eurozone wage growth, but still getting excited to hike interest rates:
- ECB survey sees moderating wage demands, selling price growth
- Markets price in two ECB rate hikes by early 2027 on inflation concerns
- Wall Street ends lower as oil prices rise, investors await big tech earnings
- Tuesday, 21 July 2026
-
- Signs and portents for the U.S. economy:
- Oil prices rise to five-week high on US-Iran attacks, Houthi blockade threat
- Economists think Fed minions won’t hike U.S. interest rates in 2026, but think there’s a chance they will:
- Bigger trouble developing in China:
- China considers tighter export controls on AI models and chips, FT reports
- China’s world-leading renewable megabases rely on coal-heavy transmission, report finds
- China’s steel sector looks weaker than it is, reverse for iron ore
- ECB minions clamp down on Eurozone credit:
- Dow gains nearly 400 points; S&P 500 snaps 3-day losing run as chip stocks rise
- Wednesday, 22 July 2026
-
- Signs and portents for the U.S. economy:
- US 30-year mortgage hits 11-month high, MBA says
- Oil climbs over 3% to near six-week high as conflict threatens key oil transit routes
- BOJ minions fear yen’s decline will continue, standing by to hike interest rates to prop up Japan’s currency:
- Yen steadies near 40-year low on rate-hike bets, intervention talks
- ECB minions standing by to hike Eurozone interest rates later:
- Wall Street ends red as U.S. stocks struggle ahead of Tesla, Alphabet results
- Thursday, 23 July 2026
-
- Signs and portents for the U.S. economy:
- How the hunt for value sparked a US private-label revolution
- AI will not trigger employment collapse, staffing company Adecco Group says
- Oil prices rise for a fifth day as US-Iran hostilities threaten supply routes
- Fed minions keeping mum, including the hawkish ones who want to hike interest rates:
- BOJ minions / Bigger trouble developing in Japan:
- ECB minions worrying about rising oil prices again, but strangely choose to leave Eurozone interest rates unchanged if they really believe inflationary shock is coming:
- Oil price surge reignites inflation worries ahead of ECB meeting
- ECB Keeps Rates Unchanged (As Expected), Warns ‘Full Energy Inflationary Shock Yet To Come’
- ECB minions also thinking about other things:
- ECB considering several options to mitigate losses, sources say
- ECB will discuss raising banks’ minimum reserves, Lagarde says
- U.S. stocks end lower as oil reaches $100/bbl; investors assess tech results
- Friday, 24 July 2026
-
- Signs and portents for the U.S. economy:
- Oil retreats from above $100, still set for weekly rise on Middle East escalation
- US business activity perks up in July, helped by World Cup, but trend may not last, S&P Global says
- Fed minions being told by markets how to set interest rates:
- BOJ minions live up to expectations as bigger trouble develops in Japan:
- Yen heads for biggest weekly drop since May despite Tokyo’s support pledges
- ECB minions get data indicating no changes in Eurozone inflation outlook:
- S&P 500 posts weekly loss while defensive sectors outperform
The Atlanta Fed’s GDPNow tool‘s estimate of real GDP growth for the U.S. economy in the current quarter of 2026-Q2 was unchanged at +1.7%, with no updates in the past week.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bear scaring a bull with a stage presentation on ‘WHY BULLS SHOULD BE SCARED’ with three easels set up that say ‘OIL PRICES’, ‘RATE HIKES’ and ‘AI CAPEX COSTS’”. The tag indicating the image was “AI generated” is something new, but hopefully no surprise to any of our readers who read all our articles down to this bottom line!
Source: https://politicalcalculations.blogspot.com/2026/07/s-500-declines-as-higher-oil-prices-ai.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.



